Research Article
Factors Affecting Intensive Aflibercept Treatment Response in Diabetic Macular Edema: A Real-World Study
Table 3
Comparison of baseline characteristics between good and suboptimal responders.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Statistically significant difference () in Mann–Whitney -test and Wilcoxon signed-rank test. SD: standard deviation; N: number; DM: diabetes mellitus; HbA1c: glycated hemoglobin; OHA: oral hypoglycemic agents; Hb: hemoglobin; WBC: white blood cell; Plt: platelet; eGFR: estimated glomerular filtration rates; Cr: creatinine; Ca: calcium; Na: sodium; K: potassium; Cl: chloride; Alb: albumin; AST: aspartate aminotransferase test; ALT: alanine aminotransferase test; HTN: hypertension; HL: hyperlipidemia; CRT: central retinal thickness; BCVA: best-corrected visual acuity; DMR: diabetic retinopathy; (N)PDR: (non)proliferative diabetic retinopathy; ERM: epiretinal membrane; PRP: panretinal photocoagulation. |